Fei Huang - Concepedia

Author

Fei Huang

Bristol-Myers Squibb (United States)ORCID

Also Known As

F Huang, F. HUANG, F. Huang, FEI HUANG, Fei HUANG, Fei Huang, Fei Huang -, Fei Huiping huang, Huang Fei, Huang, Fei

273

Publications

8.7K

Citations

H-Index

176

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Fujian Medical University Binzhou University First Affiliated Hospital of Fujian Medical University Sun Yat-sen University

About

Fei Huang is an author at Bristol-Myers Squibb (United States) specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	47	1.9K
2	Engineering	9	9	500
3	Health Sciences	7	7	265
4	Natural Sciences	2	2	48
5	Public Health	1	1	81

Fei Huang

133

Publications

8.2K

Citations

H-Index

Page 1

	Year	Citations
Dasatinib in Imatinib-Resistant Philadelphia Chromosome–Positive Leukemias Moshe Talpaz, Neil P. Shah, Hagop M. Kantarjian, New England Journal of Medicine	2006	1.8K
Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts Yudi Pawitan, Judith Bjöhle, Lukas C. Amler, Breast Cancer Research	2005	816
Identification of Candidate Molecular Markers Predicting Sensitivity in Solid Tumors to Dasatinib: Rationale for Patient Selection Fei Huang, Karen A. Reeves, Xia Han, Cancer Research	2007	337
Regulation of TGF-β receptor activity Fei Huang, Ye‐Guang Chen Cell & Bioscience	2012	223
Rapid isolation of cancer cells using microfluidic deterministic lateral displacement structure Zongbin Liu, Fei Huang, Jinghui Du, Biomicrofluidics EngineeringOrgan-on-a-chipBiomedical EngineeringCancer EngineeringNanomedicine	2013	212
The Mechanisms of Differential Sensitivity to an Insulin-like Growth Factor-1 Receptor Inhibitor (BMS-536924) and Rationale for Combining with EGFR/HER2 Inhibitors Fei Huang, Ann Greer, Warren Hurlburt, Cancer Research	2008	163
c-Cbl-Mediated Neddylation Antagonizes Ubiquitination and Degradation of the TGF-β Type II Receptor Wei Zuo, Fei Huang, Y. Jeffrey Chiang, Molecular Cell Molecular PharmacologySignal TransductionSignaling PathwayCell RegulationImmunology	2013	146
Colorectal cancers with microsatellite instability display mRNA expression signatures characteristic of increased immunogenicity Ayan Banerjea, Shafi Ahmed, Rebecca Hands, Molecular Cancer	2004	135
High IGF-IR Activity in Triple-Negative Breast Cancer Cell Lines and Tumorgrafts Correlates with Sensitivity to Anti–IGF-IR Therapy Beate C. Litzenburger, Chad J. Creighton, Anna Tsimelzon, Clinical Cancer Research	2010	129
Microwave ablation versus laparoscopic resection as first‐line therapy for solitary 3–5‐cm HCC Zhen Wang, Miao Liu, Dezhi Zhang, Hepatology	2022	124

Page 1